Approval for the cypher sirolimus-eluting coronary stent on the raptor over-the-wire delivery system or raptorrail rapid exchange delivery system.  The device is indicated for improving coronary luminal diameter in patients with symptomatic ischemic disease due to discrete de novo lesions of length <= 30 mm in native coronary arteries with a reference vessel diameter of >= 2.5 to <= 3.5 mm.  Long-term outcome (beyond 12 months) for this permanent implant is unknown at present.